Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
Hatta K, Otachi T, Fujita K, Morikawa F, Ito S, Tomiyama H, Abe T, Sudo Y, Takebayashi H, Yamashita T, Katayama S, Nakase R, Shirai Y, Usui C, Nakamura H, Ito H, Hirata T, Sawa Y; JAST study group. Hatta K, et al. Among authors: abe t. Schizophr Res. 2014 Sep;158(1-3):213-22. doi: 10.1016/j.schres.2014.07.015. Epub 2014 Jul 31. Schizophr Res. 2014. PMID: 25086659 Free article. Clinical Trial.
A prospective naturalistic multicenter study on choice of parenteral medication in psychiatric emergency settings in Japan.
Hatta K, Katayama S, Morikawa F, Imai A, Fujita K, Fujita A, Ishizuka T, Abe T, Sudo Y, Hashimoto K, Usui C, Nakamura H, Yamanouchi Y, Hirata T; JAST study group. Hatta K, et al. Among authors: abe t. Neuropsychopharmacol Rep. 2018 Sep;38(3):117-123. doi: 10.1002/npr2.12015. Epub 2018 May 24. Neuropsychopharmacol Rep. 2018. PMID: 30175524 Free PMC article.
Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study.
Takeuchi H, Suzuki T, Remington G, Bies RR, Abe T, Graff-Guerrero A, Watanabe K, Mimura M, Uchida H. Takeuchi H, et al. Among authors: abe t. Schizophr Bull. 2013 Sep;39(5):993-8. doi: 10.1093/schbul/sbt090. Epub 2013 Jul 1. Schizophr Bull. 2013. PMID: 23821768 Free PMC article. Clinical Trial.
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.
Nakajima S, Uchida H, Suzuki T, Watanabe K, Hirano J, Yagihashi T, Takeuchi H, Abe T, Kashima H, Mimura M. Nakajima S, et al. Among authors: abe t. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1983-9. doi: 10.1016/j.pnpbp.2011.08.008. Epub 2011 Aug 24. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21889560 Clinical Trial.
Baseline difference between patients' and clinicians' rated illness severity scores and subsequent outcomes in major depressive disorder: analysis of the sequenced treatment alternatives to relieve depression data.
Tada M, Uchida H, Suzuki T, Abe T, Pollock BG, Mimura M. Tada M, et al. Among authors: abe t. J Clin Psychopharmacol. 2014 Jun;34(3):297-302. doi: 10.1097/JCP.0000000000000112. J Clin Psychopharmacol. 2014. PMID: 24743720 Free PMC article. Clinical Trial. No abstract available.
Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: A randomized, parallel-group, non-inferiority trial.
Nakagome K, Yokoi Y, Nakagawa A, Tani M, Nishioka G, Yoshimura N, Furukawa TA, Watanabe K, Mimura M, Iwanami A, Abe T. Nakagome K, et al. Among authors: abe t. J Affect Disord. 2021 Mar 1;282:1011-1020. doi: 10.1016/j.jad.2020.12.148. Epub 2021 Jan 5. J Affect Disord. 2021. PMID: 33601673 Free article. Clinical Trial.
Phase I/II Study of Intrathecal Administration of Recombinant Human Hepatocyte Growth Factor in Patients with Acute Spinal Cord Injury: A Double-Blind, Randomized Clinical Trial of Safety and Efficacy.
Nagoshi N, Tsuji O, Kitamura K, Suda K, Maeda T, Yato Y, Abe T, Hayata D, Matsumoto M, Okano H, Nakamura M. Nagoshi N, et al. Among authors: abe t. J Neurotrauma. 2020 Aug 1;37(15):1752-1758. doi: 10.1089/neu.2019.6854. Epub 2020 May 22. J Neurotrauma. 2020. PMID: 32323609 Clinical Trial.
9,118 results